Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Early Phase 1

4(66.7%)

Phase 1

1(16.7%)

Phase 4

1(16.7%)

6Total

Early Phase 1(4)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06393634Early Phase 1Completed

Comparing Direct and Indirect Detection Methods of Multiple Routes of Testosterone Administration

Role: lead

NCT05450900Early Phase 1Completed

Can Biotin Supplementation be Used to Mask hCG Abuse?

Role: lead

NCT04073849Early Phase 1Completed

CD71 in Dried Blood Spots in Healthy Males

Role: lead

NCT02611154Phase 4Completed

Intranasal Delivery of Testosterone and Its Effect on Doping Markers

Role: collaborator

NCT03028532Phase 1Completed

Administration of Clomiphene: Short and Long Term Metabolism in an Anti-Doping Setting

Role: collaborator

NCT02684747Early Phase 1Completed

Detecting Autologous Transfusion by Measuring Alterations in the Dynamics of Red Blood Cell Maturation and Recycling

Role: collaborator

All 6 trials loaded